* We recommend a score >= 0.08 for meaningful Gene-Disease associations
| GeneID | Gene_Symbol | DisGeNet_diseaseID | Disease_name | DisGeNet_sourceDB | |
| 2167 | FABP4 | C0024668 | Mammary Neoplasms, Experimental | 0.2 | CTD_human |
| 2167 | FABP4 | C0024667 | Animal Mammary Neoplasms | 0.2 | CTD_human |
| 2167 | FABP4 | C0011616 | Contact Dermatitis | 0.2 | CTD_human |
| 2167 | FABP4 | C0028754 | Obesity | 0.0062532035022714 | BEFREE;GAD |
| 2167 | FABP4 | C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 0.0037806624443535 | BEFREE;GAD |
| 2167 | FABP4 | C0010068 | Coronary heart disease | 0.00328236603323995 | BEFREE;LHGDN |
| 2167 | FABP4 | C0003850 | Arteriosclerosis | 0.0030219946263441 | BEFREE |
| 2167 | FABP4 | C0242339 | Dyslipidemias | 0.00300763924902685 | BEFREE;LHGDN |
| 2167 | FABP4 | C0004153 | Atherosclerosis | 0.002747267842131 | BEFREE |
| 2167 | FABP4 | C0032914 | Pre-Eclampsia | 0.00273291246481375 | LHGDN |
| 2167 | FABP4 | C0007138 | Carcinoma, Transitional Cell | 0.00273291246481375 | LHGDN |
| 2167 | FABP4 | C0024236 | Lymphedema | 0.002407028523288 | GAD |
| 2167 | FABP4 | C0020443 | Hypercholesterolemia | 0.002407028523288 | GAD |
| 2167 | FABP4 | C0524620 | Metabolic Syndrome X | 0.0013736339210655 | BEFREE |
| 2167 | FABP4 | C0011849 | Diabetes Mellitus | 0.0008241803526393 | BEFREE |
| 2167 | FABP4 | C0577631 | Carotid Atherosclerosis | 0.0008241803526393 | BEFREE |
| 2167 | FABP4 | C0596263 | Carcinogenesis | 0.0008241803526393 | BEFREE |
| 2167 | FABP4 | C0011847 | Diabetes | 0.0005494535684262 | BEFREE |
| 2167 | FABP4 | C0376358 | Malignant neoplasm of prostate | 0.0005494535684262 | BEFREE |
| 2167 | FABP4 | C0600139 | Prostate carcinoma | 0.0005494535684262 | BEFREE |
| 2167 | FABP4 | C0678222 | Breast Carcinoma | 0.0005494535684262 | BEFREE |
| 2167 | FABP4 | C3642345 | Luminal A Breast Carcinoma | 0.0005494535684262 | BEFREE |
| 2167 | FABP4 | C3539878 | Triple Negative Breast Neoplasms | 0.0005494535684262 | BEFREE |
| 2167 | FABP4 | C0032460 | Polycystic Ovary Syndrome | 0.0005494535684262 | BEFREE |
| 2167 | FABP4 | C0029925 | Ovarian Carcinoma | 0.0005494535684262 | BEFREE |
| 2167 | FABP4 | C0006142 | Malignant neoplasm of breast | 0.0005494535684262 | BEFREE |
| 2167 | FABP4 | C1140680 | Malignant neoplasm of ovary | 0.0005494535684262 | BEFREE |
| 2167 | FABP4 | C2362324 | Pediatric Obesity | 0.0005494535684262 | BEFREE |
| 2167 | FABP4 | C0010054 | Coronary Arteriosclerosis | 0.0005494535684262 | BEFREE |
| 2167 | FABP4 | C1956346 | Coronary Artery Disease | 0.0005494535684262 | BEFREE |
| 2167 | FABP4 | C0948480 | Coronary Restenosis | 0.0002747267842131 | BEFREE |
| 2167 | FABP4 | C1301700 | Cardiovascular morbidity | 0.0002747267842131 | BEFREE |
| 2167 | FABP4 | C3272363 | Ischemic Cerebrovascular Accident | 0.0002747267842131 | BEFREE |
| 2167 | FABP4 | C0948089 | Acute Coronary Syndrome | 0.0002747267842131 | BEFREE |
| 2167 | FABP4 | C2711227 | Steatohepatitis | 0.0002747267842131 | BEFREE |
| 2167 | FABP4 | C0948008 | Ischemic stroke | 0.0002747267842131 | BEFREE |
| 2167 | FABP4 | C0699885 | Carcinoma of bladder | 0.0002747267842131 | BEFREE |
| 2167 | FABP4 | C1370507 | Cerebellar Liponeurocytoma | 0.0002747267842131 | BEFREE |
| 2167 | FABP4 | C4022459 | Fat tissue decreased | 0.0002747267842131 | BEFREE |
| 2167 | FABP4 | C1536220 | ST segment elevation myocardial infarction | 0.0002747267842131 | BEFREE |
| 2167 | FABP4 | C0549473 | Thyroid carcinoma | 0.0002747267842131 | BEFREE |
| 2167 | FABP4 | C0040021 | Thromboangiitis Obliterans | 0.0002747267842131 | BEFREE |
| 2167 | FABP4 | C0025149 | Medulloblastoma | 0.0002747267842131 | BEFREE |
| 2167 | FABP4 | C0004096 | Asthma | 0.0002747267842131 | BEFREE |
| 2167 | FABP4 | C0005684 | Malignant neoplasm of urinary bladder | 0.0002747267842131 | BEFREE |
| 2167 | FABP4 | C0005695 | Bladder Neoplasm | 0.0002747267842131 | BEFREE |
| 2167 | FABP4 | C0007115 | Malignant neoplasm of thyroid | 0.0002747267842131 | BEFREE |
| 2167 | FABP4 | C0007222 | Cardiovascular Diseases | 0.0002747267842131 | BEFREE |
| 2167 | FABP4 | C0007282 | Carotid Stenosis | 0.0002747267842131 | BEFREE |
| 2167 | FABP4 | C0011881 | Diabetic Nephropathy | 0.0002747267842131 | BEFREE |
| 2167 | FABP4 | C0017667 | Nodular glomerulosclerosis | 0.0002747267842131 | BEFREE |
| 2167 | FABP4 | C0023787 | Lipodystrophy | 0.0002747267842131 | BEFREE |
| 2167 | FABP4 | C0520679 | Sleep Apnea, Obstructive | 0.0002747267842131 | BEFREE |
| 2167 | FABP4 | C0027051 | Myocardial Infarction | 0.0002747267842131 | BEFREE |
| 2167 | FABP4 | C0027627 | Neoplasm Metastasis | 0.0002747267842131 | BEFREE |
| 2167 | FABP4 | C0036341 | Schizophrenia | 0.0002747267842131 | BEFREE |
| 2167 | FABP4 | C0041582 | Ulcer | 0.0002747267842131 | BEFREE |
| 2167 | FABP4 | C0042373 | Vascular Diseases | 0.0002747267842131 | BEFREE |
| 2167 | FABP4 | C0153690 | Secondary malignant neoplasm of bone | 0.0002747267842131 | BEFREE |
| 2167 | FABP4 | C0206081 | Hyperandrogenism | 0.0002747267842131 | BEFREE |
| 2167 | FABP4 | C0400966 | Non-alcoholic Fatty Liver Disease | 0.0002747267842131 | BEFREE |
| 2167 | FABP4 | C0424295 | Hyperactive behavior | 0.0002747267842131 | BEFREE |